Improvement of the Antioxidant and Antitumor Activities of Benzimidazole-Chitosan Quaternary Ammonium Salt on Drug Delivery Nanogels
Open Access
- 11 January 2024
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 22 (1) , 40
Abstract
The present study focused on the design and preparation of acid-responsive benzimidazole-chitosan quaternary ammonium salt (BIMIXHAC) nanogels for a controlled, slow-release of Doxorubicin HCl (DOX.HCl). The BIMIXHAC was crosslinked with sodium tripolyphosphate (TPP) using the ion crosslinking method. The method resulted in nanogels with low polydispersity index, small particle size, and positive zeta potential values, indicating the good stability of the nanogels. Compared to hydroxypropyl trimethyl ammonium chloride chitosan-Doxorubicin HCl-sodium tripolyphosphate (HACC-D-TPP) nanogel, the benzimidazole-chitosan quaternary ammonium salt-Doxorubicin HCl-sodium tripolyphosphate (BIMIXHAC-D-TPP) nanogel show higher drug encapsulation efficiency and loading capacity (BIMIXHAC-D-TPP 93.17 ± 0.27% and 31.17 ± 0.09%), with acid-responsive release profiles and accelerated release in vitro. The hydroxypropyl trimethyl ammonium chloride chitosan-sodium tripolyphosphate (HACC-TPP), and benzimidazole-chitosan quaternary ammonium salt-sodium tripolyphosphate (BIMIXHAC-TPP) nanogels demonstrated favorable antioxidant capability. The assay of cell viability, measured by the MTT assay, revealed that nanogels led to a significant reduction in the cell viability of two cancer cells: the human lung adenocarcinoma epithelial cell line (A549) and the human breast cancer cell line (MCF-7). Furthermore, the BIMIXHAC-D-TPP nanogel was 2.96 times less toxic than DOX.HCl to the mouse fibroblast cell line (L929). It was indicated that the BIMIXHAC-based nanogel with enhanced antioxidant and antitumor activities and acidic-responsive release could serve as a potential nanocarrier.Keywords
Funding Information
- 2023 annual Special Research Assistant Project of the Chinese Academy of Sciences (2022CXGC020413, 2020219, ZR2022QB220)
- Shandong Key R&D Plan, Major Scientific and Technological Innovation Project (2022CXGC020413, 2020219, ZR2022QB220)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2022CXGC020413, 2020219, ZR2022QB220)
- Natural Science Foundation of Shandong Province of China (2022CXGC020413, 2020219, ZR2022QB220)
This publication has 68 references indexed in Scilit:
- Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the artSaudi Pharmaceutical Journal, 2016
- Cardiomyocyte autophagy and cancer chemotherapyJournal of Molecular and Cellular Cardiology, 2014
- Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeuticsInternational Journal of Pharmaceutics, 2013
- Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptakeNature Neuroscience, 2013
- Control of Swelling of Responsive Nanogels by NanoconfinementSmall, 2012
- Maytansinoid-Antibody Conjugates Induce Mitotic Arrest by Suppressing Microtubule Dynamic InstabilityMolecular Cancer Therapeutics, 2010
- The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in ratEuropean Journal of Pharmacology, 2010
- Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human LiverDrug Metabolism and Disposition, 2008
- Morphine is protective against doxorubicin-induced cardiotoxicity in ratToxicology, 2008
- Pathogen recognition and development of particulate vaccines: Does size matter?Methods, 2006